CAFFEINE SODIUM SALICYLATE

Suppliers

Names

[ CAS No. ]:
8002-85-5

[ Name ]:
CAFFEINE SODIUM SALICYLATE

[Synonym ]:
potassium caffeine o-hydroxybenzoate
Caffeine-sodium salicylate mixture
Sodium salicylate,compd. with caffeine (7CI)
Benzoic acid,2-hydroxy-,monosodium salt,mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
Sodium salicylate,compd. with caffeine
Caffeine sodium salicylate

Chemical & Physical Properties

[ Boiling Point ]:
416.8ºC at 760 mmHg

[ Molecular Formula ]:
C15H15N4NaO5

[ Molecular Weight ]:
354.29300

[ Flash Point ]:
205.9ºC

[ Exact Mass ]:
354.09400

[ PSA ]:
122.18000

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DH2526500
CHEMICAL NAME :
Benzoic acid, 2-hydroxy-, monosodium salt, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine- 2,6-dione
CAS REGISTRY NUMBER :
8002-85-5
LAST UPDATED :
198909
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C8-H10-N4-O2.C7-H5-O3.Na

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
150 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 131,171,1928
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraarterial
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
150 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 131,171,1928

Related Compounds

  • caffeine-sodium benzoate
  • 2-hydroxybenzoic acid,1,3,7-trimethylpurine-2,6-dione
  • Sodium salicylate
  • Sodium Salicylate
  • caffeine dimer
  • Caffeine
  • 1-[2-(ethylsulfanyl)ethyl]-5-(1-methyl-1H-pyrazol-5-yl)-1H-1,2,3-triazol-4-amine
  • 1-(2-Chlorophenyl)-4-methylcyclohex-2-en-1-ol
  • 1-(5-fluoropentyl)-5-(1-methyl-1H-pyrazol-5-yl)-1H-1,2,3-triazol-4-amine
  • 4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-2-carboxylic acid
  • 2-Fluoro-3-methoxy-6-(trifluoromethyl)benzoic acid
  • 2-(Difluoromethoxy)-4-fluorobenzene-1-sulfonyl fluoride
  • 5-(4-Methoxy-1,3-benzothiazol-2-yl)-2-phenyl-octahydropyrrolo[3,4-c]pyrrole-1,3-dione
  • 6-Cyclopropyl-2-[1-(4-methyl-1,2,3-thiadiazole-5-carbonyl)piperidin-4-yl]-1,8-naphthyridine
  • 2-[3-(N-methylcyclopropanesulfonamido)piperidin-1-yl]-N-[3-(trifluoromethyl)phenyl]acetamide
  • 3-oxo-1-(trimethyl-1H-pyrazol-4-yl)cyclobutane-1-carboxylic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.